Cargando…

Human Immunodeficiency Virus-1 Latency Reversal via the Induction of Early Growth Response Protein 1 to Bypass Protein Kinase C Agonist-Associated Immune Activation

Human Immunodeficiency Virus-1 (HIV) remains a global health challenge due to the latent HIV reservoirs in people living with HIV (PLWH). Dormant yet replication competent HIV harbored in the resting CD4+ T cells cannot be purged by antiretroviral therapy (ART) alone. One approach of HIV cure is the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Lilly M., Li, Dajiang, Tang, Yuyang, Méndez-Lagares, Gema, Thompson, George R., Hartigan-O’Connor, Dennis J., Dandekar, Satya, Jiang, Guochun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960990/ https://www.ncbi.nlm.nih.gov/pubmed/35359743 http://dx.doi.org/10.3389/fmicb.2022.836831

Ejemplares similares

Deep latency: A new insight into a functional HIV cure
por: Elsheikh, Maher M., et al.
Publicado: (2019)

Eradication of human immunodeficiency virus-1 reservoir in the brain microglia
por: Tang, Yuyang, et al.
Publicado: (2022)

Persistent effects of early infant diet and associated microbiota on the juvenile immune system
por: Narayan, Nicole R, et al.
Publicado: (2015)

Depletion of HIV reservoir by activation of ISR signaling in resting CD4(+) T cells
por: Li, Dajiang, et al.
Publicado: (2022)

Feline immunodeficiency virus latency
por: McDonnel, Samantha J, et al.
Publicado: (2013)

Recent developments in human immunodeficiency virus-1 latency research
por: Chan, Chi Ngai, et al.
Publicado: (2013)

Human Immunodeficiency Virus 1 (HIV-1): Viral Latency, the Reservoir, and the Cure
por: Ventura, John D.
Publicado: (2020)

Human Immunodeficiency Virus (HIV)-1 Integration Sites in Viral Latency
por: Rezaei, Simin D., et al.
Publicado: (2015)

Cytomegalovirus (CMV) Infection and Latency
por: O’Connor, Christine M.
Publicado: (2021)

In vitro effects of the small-molecule protein kinase C agonists on HIV latency reactivation
por: Brogdon, Jessica, et al.
Publicado: (2016)

Establishment of HSV1 Latency in Immunodeficient Mice Facilitates Efficient In Vivo Reactivation
por: Ramakrishna, Chandran, et al.
Publicado: (2015)

Role of Polycomb Proteins in Regulating HSV-1 Latency
por: Watson, Zachary, et al.
Publicado: (2013)

Transient Effect of Infant Formula Supplementation on the Intestinal Microbiota
por: Chin, Ning, et al.
Publicado: (2021)

Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication
por: Miller, Leia K, et al.
Publicado: (2013)

Human Immunodeficiency Virus Type-1 (HIV-1) Transcriptional Regulation, Latency and Therapy in the Central Nervous System
por: Hokello, Joseph, et al.
Publicado: (2021)

Regulation of the MIE Locus During HCMV Latency and Reactivation
por: Dooley, Abigail L., et al.
Publicado: (2020)

Identification of HIV-1 Tat-Associated Proteins Contributing to HIV-1 Transcription and Latency
por: Jean, Maxime Junior, et al.
Publicado: (2017)

A Latency-Optimized Network-on-Chip with Rapid Bypass Channels
por: Ma, Wenheng, et al.
Publicado: (2021)

HIV Exploits Antiviral Host Innate GCN2-ATF4 Signaling for Establishing Viral Replication Early in Infection
por: Jiang, Guochun, et al.
Publicado: (2017)

Divergent Annexin A1 expression in periphery and gut is associated with systemic immune activation and impaired gut immune response during SIV infection
por: Sena, Angela A. S., et al.
Publicado: (2016)

Chemokines and Chemokine Receptors: Accomplices for Human Immunodeficiency Virus Infection and Latency
por: Wang, Zhuo, et al.
Publicado: (2017)

The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1
por: López-Huertas, María Rosa, et al.
Publicado: (2017)

HIV-1 Latency and Latency Reversal: Does Subtype Matter?
por: Sarabia, Indra, et al.
Publicado: (2019)

Modulation of host cell signaling during cytomegalovirus latency and reactivation
por: Smith, Nicholas A., et al.
Publicado: (2021)

New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
por: Lewis, Catherine A., et al.
Publicado: (2023)

Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins
por: Khan, Sheraz, et al.
Publicado: (2018)

Identification of a novel protein encoded by the latency-related gene of bovine herpesvirus 1
por: Meyer, Florencia, et al.
Publicado: (2007)

Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents
por: Delagrèverie, Héloïse M., et al.
Publicado: (2016)

Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation
por: Jiang, Guochun, et al.
Publicado: (2015)

Reversible Human Immunodeficiency Virus Type-1 Latency in Primary Human Monocyte-Derived Macrophages Induced by Sustained M1 Polarization
por: Graziano, Francesca, et al.
Publicado: (2018)

Cytomegalovirus infection disrupts the influence of short-chain fatty acid producers on Treg/Th17 balance
por: Chin, Ning, et al.
Publicado: (2022)

Crotonylation sensitizes IAPi-induced disruption of latent HIV by enhancing p100 cleavage into p52
por: Li, Dajiang, et al.
Publicado: (2021)

Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency
por: Pasternak, Alexander O., et al.
Publicado: (2023)

Lenalidomide downregulates ACE2 protein abundance to alleviate infection by SARS-CoV-2 spike protein conditioned pseudoviruses
por: Su, Siyuan, et al.
Publicado: (2021)

Macrophage chemoattractant protein 1 and outcome in cardiopulmonary bypass
por: Pereira, KC, et al.
Publicado: (2005)

The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate
por: Bobardt, Michael, et al.
Publicado: (2019)

p30 protein: a critical regulator of HTLV-1 viral latency and host immunity
por: Moles, Ramona, et al.
Publicado: (2019)

FKBP3 Induces Human Immunodeficiency Virus Type 1 Latency by Recruiting Histone Deacetylase 1/2 to the Viral Long Terminal Repeat
por: Yang, Xinyi, et al.
Publicado: (2021)

P300 Latency and Neurocognitive Functioning in Recently Diagnosed Human Immunodeficiency Virus Patients
por: Nehra, Ritu, et al.
Publicado: (2012)

The microRNA miR-29a is associated with human immunodeficiency virus latency
por: Patel, Paresh, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qcigenbpqmj7ujm9ukeiabvitf